**Core tip:** This paper used propensity score-matched analysis and questionnaire survey to evaluate the short-term outcomes and quality of life (QoL) in patients who underwent digestive tract reconstruction using the isoperistaltic jejunum-later-cut overlap method (IJOM) after totally laparoscopic total gastrectomy (TLTG) and in patients who underwent Roux-en-Y anastomosis after laparoscopic-assisted total gastrectomy. We found the IJOM for digestive reconstruction after TLTG is associated with reduced blood loss and less pain and dysphagia, thus improving the QoL after laparoscopic gastrectomy.

INTRODUCTION
============

Since Kitano et al\[[@B1]\] reported laparoscopic-assisted distal gastrectomy in 1991, laparoscopic techniques and instruments have improved substantially. Consequently, totally laparoscopic distal gastrectomy is increasingly employed and has a proven history of safety and feasibility\[[@B2]-[@B8]\]. However, although scholars have reported a variety of totally laparoscopic total gastrectomy (TLTG) methods\[[@B3],[@B9]-[@B13]\], this technique has not been widely adopted because of the technological difficulty inherent in digestive reconstruction. Interest in improving the postoperative appearance and quality of life (QoL) in patients with gastric cancer has been increased. This goal, combined with the reduced trauma associated with TLTG, has heightened interest in developing ways to improve TLTG. Surgeons have primarily adopted the overlap or functional end-to-end method for digestive tract reconstruction after TLTG. However, these methods have drawbacks, such as jejunal freeness, which is seen particularly frequently with large anastomoses. Therefore, we devised the isoperistaltic jejunum-later-cut overlap method (IJOM), which involves esophagojejunostomy anastomosis after TLTG. Using this technique, we believe that the jejunum can be positioned with greater ease, thereby reducing the difficulties encountered with the anastomosis. However, little is known about the short-term outcomes and QoL of patients following the implementation of this IJOM for digestive reconstruction after TLTG. Thus, this study aimed to assess the short-term outcomes and QoL in gastric cancer patients undergoing digestive tract reconstruction with IJOM after TLTG and with Roux-en-Y anastomosis after LATG using propensity-score matching (PSM)\[[@B14],[@B15]\] and a QoL assessment scale.

MATERIALS AND METHODS
=====================

Study population and inclusion/exclusion criteria
-------------------------------------------------

Between January 2014 to March 2016, data were collected from 703 patients who underwent laparoscopic gastrectomy at Fujian Medical University Union Hospital. The including criteria were: (1) pathologically proved gastric cancer by endoscopic biopsy specimen analysis; (2) the aforementioned examination indicated no evidence of distant metastasis; and (3) postoperative pathological diagnosis was curative R0. The exclusion criteria were: (1) intraoperatively proved distant metastasis; (2) T4b stage; (3) missing pathological data; (4) neoadjuvant therapy; and (5) comorbidities that could influence QoL (*e.g*., previous or combined malignancies; cardiovascular disease; cerebrovascular disease; neurological conditions, such as dementia and seizure; and severe chronic obstructive pulmonary disease requiring persistent medical aid). A number of 507 patients were eligible. Group T consisted of 51 patients who underwent the IJOM after TLTG, and group A comprised 456 patients who received a Roux-en-Y anastomosis after LATG. The 1:2 PSM was performed. Ultimately, group T included 51 patients and group A included 102 patients (Figure [1](#F1){ref-type="fig"}).

![The flow chart of patient selection. LTG: Laparoscopic total gastrectomy; TLTG: Totally laparoscopic total gastrectomy; LATG: Laparoscopic assisted total gastrectomy.](WJG-23-7129-g001){#F1}

Anastomosis step
----------------

In group T, the IJOM was performed after TLTG. After dissecting the lymph nodes laparoscopically and mobilizing the esophagus (Figure [2A](#F2){ref-type="fig"}) and the duodenum (Figure [2B](#F2){ref-type="fig"}), an endoscopic linear stapler was used to transect them sequentially in predetermined locations. Two small incisions were made on the left side of the resection margin of the esophagus (Figure [2C](#F2){ref-type="fig"}) and the antimesenteric border of the jejunum (Figures [2D](#F2){ref-type="fig"}) approximately 20 cm away from the ligament of Treitz, respectively.

![The schematic diagram of anastomosis.](WJG-23-7129-g002){#F2}

Then, the two limbs of the stapler were inserted into each incision, respectively, and the forks of the stapler were closed and fired, achieving a side-to-side esophagojejunostomy (Figure [2E](#F2){ref-type="fig"}). After confirming that there was no bleeding *via* common stab incision (Figure [2F](#F2){ref-type="fig"}), the common stab was manually sutured (Figure [2G](#F2){ref-type="fig"}). Then, the jejunum was transected after baring the mesenteric border approximately 1 cm into the jejunum wall and approximately 3 cm away from the esophagojejunostomy (Figure [2H](#F2){ref-type="fig"}). After a small incision was made each on the antimesenteric border of the margin of the proximal jejunum and the distal jejunum roughly about 45 cm from esophagojejunostomy, the two limbs of the stapler were inserted into each incision, and the forks of the stapler were closed and fired to achieve a side-to-side jejunojejunostomy (Figure [2I](#F2){ref-type="fig"}). After confirming that there was no bleeding or damage to jejunal mucosa by common stab incision, the common stab incision was sutured laparoscopically (Figure [2J](#F2){ref-type="fig"}). Finally, we removed the specimen through a 3.5-cm incision on the lower abdomen. The differences between this method and other esophagojejunostomy anastomosis techniques are summarized in Table [1](#T1){ref-type="table"}.

###### 

Characteristics, merit and demerit of different esophagojejunostomy anastomosis techniques

  **Anastomosis surgeon**                                  **Characteristics**                                                        **Merit**                                                                  **Demerit**
  -------------------------------------------------------- -------------------------------------------------------------------------- -------------------------------------------------------------------------- ---------------------------------------------------
  Uyama et al\[[@B12]\]                                    The anastomosis line is vertical with esophageal long axis                 Anastomotic is large enough                                                The number of anastomosis linear staplers is much
  Jejunum is located in the right side of the esophagus.                                                                                                                                                         
  Matsui et al\[[@B37]\]                                   Complete the anastomosis before severed esophagus                          The number of anastomosis linear staplers is reduced                       Probably develop dysphagia 6 mo after operation
  Close the stoma and resect specimens at the same time                                                                                                                                                          
  Jejunum is located in the right side of the esophagus                                                                                                                                                          
  Lee et al\[[@B13]\]                                      Suture esophagus, jejunum and right angle of diaphragm after anastomosis   Reduce the incidence of esophageal hiatal hernia and anastomotic fistula   Increase the operation time
  Jejunum is located in the right side of the esophagus                                                                                                                                                          
  Okabe et al\[[@B38]\]                                    Before anastomosis, the specimens was removed                              The size of anastomotic stoma is bigger                                    The technique is difficult
  Jejunum is located in the left side of the esophagus                                                                                                                                                           
  Inaba et al\[[@B29]\]                                    Overlap anastomosis                                                        Isoperistaltic anastomosis meets the physiological needs                   The jejunum is free and difficult for anastomosis
  Divide the jejunum before anastomosis                                                                                                                                                                          
  Matsui et al\[[@B39]\]                                   Overlap anastomosis                                                        Isoperistaltic anastomosis meets the physiological needs                   The jejunum is free and difficult for anastomosis
  Divide the esophagus after anastomosis                                                                                                                                                                         

For patients in group T, the lymph nodes were dissected laparoscopically, and the esophagus and duodenum were mobilized. Then, the traditional open Roux-en-Y anastomosis was performed using a circular stapler\[[@B16]\].

Definition
----------

All patients signed the informed consent form before operation. Preoperative computed tomography (CT) scanning, ultrasonography of the abdomen and endoscopic ultrasonography were routinely performed. When distant metastasis was suspected, positron emission tomography was performed. Preoperative morbidities were scored according to the Charlson score system\[[@B17]\]. Tumor staging was performed according to the 7^th^ edition of the International Union against Cancer (UICC) classification\[[@B18]\]. Postoperative anastomosis-related complications were diagnosed by gastrografin esophagram or clinical manifestations and stratified using the Clavien-Dindo classification\[[@B19]\]. Perioperative death was defined as death that occurred during hospitalization. The Institutional Review Board of Fujian Medical University Union Hospital approved this study.

QoL questionnaire
-----------------

We used the validated Chinese version of the European Organization for Research and Treatment of Cancer 30-item core QoL questionnaire (EORTC-QLQ-C30)\[[@B20]\] to assess QoL. The questionnaire includes a global health status, five functional items, three symptom dimensions, and six individual symptom items (Table [2](#T2){ref-type="table"}). Furthermore, we used the validated Chinese version of the 22-item EORTC-QLQ gastric cancer module (EORTC-QLQ-STO22)\[[@B21]\] to assess tumor-specific QoL. This questionnaire includes a functional scale, five symptom dimensions, and three individual symptom scales. QoL is represented by a score ranging from 0 to 100 for every scale. Better QoL is indicated by the higher scores in the functional scales of the EORTC-QLQ-C30 and lower scores in the symptom scores of EORTC-QLQ-C30 and STO22 (Table [2](#T2){ref-type="table"}).

###### 

Structure of EORTC QLC-C30 and EORTC QLQ-STO22

  **Scale**                                                        **Number of constituting items**
  ---------------------------------------------------------------- ----------------------------------
  EORTC QLQ-C30                                                    
  Global health status/QoL scale[1](#T2FN1){ref-type="table-fn"}   2
  Functional scales[1](#T2FN1){ref-type="table-fn"}                
  Physical functioning                                             5
  Role functioning                                                 2
  Emotional functioning                                            4
  Cognitive functioning                                            2
  Social functioning                                               2
  Symptom scales[2](#T2FN2){ref-type="table-fn"}                   
  Fatigue                                                          3
  Nausea and vomiting                                              2
  Pain                                                             2
  Dyspnoea                                                         1
  Insomnia                                                         1
  Appetite loss                                                    1
  Constipation                                                     1
  Diarrhoea                                                        1
  Financial difficulties                                           1
  EORTC-QLQ-STO22[2](#T2FN2){ref-type="table-fn"}                  
  Dysphagia                                                        3
  Chest and abdominal pain                                         4
  Reflux                                                           3
  Eating restrictions                                              4
  Anxieties                                                        3
  Dry mouth                                                        1
  Taste problem                                                    1
  Body image                                                       1
  Hair loss                                                        2

Higher scores represent better QoL;

Higher scores represent worse QoL. EORTC QLQ indicates European Organization for Research and Treatment of Cancer Quality-of-life Questionnaire; QoL: Quality-of-life.

Follow-up
---------

The follow-ups were performed *via* mailing, telephone call, or outpatient service. We explained the content of each item of the questionnaire to the patients 6 mo postoperatively, and the patients chose their own responses. Most patients underwent physical examinations, laboratory tests, chest radiography, abdominal ultrasonography or CT, and annual endoscopic examinations.

Statistical analysis
--------------------

The Statistical Package for Social Science version 18.0 (SPSS, Chicago, IL, United States) was used to perform statistical analyses. The *t* tests or paired *t* tests were performed to compare continuous variables. χ^2^ tests were performed to compare categorical variables. *P* \< 0.05 was considered statistically significant.

RESULTS
=======

Demographics and clinical characteristics
-----------------------------------------

Before matching, age, sex, tumor location, tumor size, and preoperative albumin level differed significantly between the two groups (*P* \< 0.05). After 1:2 matching, 51 and 102 patients were included in groups T and A, respectively, and well balanced in their clinicopathological characteristics (Table [3](#T3){ref-type="table"}).

###### 

Demographic and clinical characteristics of patients in the two groups

                                          **All patients**   **Propensity-matched patients**                                          
  --------------------------------------- ------------------ --------------------------------- ---------- ------------- ------------- -------
  Age (mean ± SD, yr)                     55.5 ± 12.1        61.6 ± 11.2                       \< 0.001   55.5 ± 12.1   55.9 ± 11.0   0.916
  Gender                                                                                       \< 0.001                               1.000
  Male                                    34                 345                                          34            68            
  Female                                  17                 111                                          17            34            
  Charlson comorbidity index                                                                   0.281                                  0.608
  0                                       48                 418                                          48            92            
  1-2                                     3                  38                                           3             10            
  BMI (mean ± SD, kg/m^2^)                22.5 ± 13.1        22.3 ± 13.5                       0.919      22.5 ± 13.1   22.6 ± 12.8   0.965
  Tumor size (mean ± SD, cm)              4.5 ± 1.5          4.9 ± 1.3                         0.041      4.5 ± 1.5     4.7 ± 1.7     0.142
  Tumor location                                                                               \< 0.001                               0.177
  Upper third                             4                  188                                          4             12            
  Middle third                            34                 169                                          34            76            
  Whole                                   13                 99                                           13            14            
  Histology type                                                                               0.453                                  0.482
  Differentiation                         47                 416                                          47            97            
  Undifferentiation                       4                  40                                           4             5             
  Preoperative albumin (mean ± SD, g/L)   40.8 ± 4.3         39.1 ± 5.2                        0.025      40.8 ± 4.3    40.6 ± 4.6    0.796
  Depth of infiltration (T)                                                                    0.174                                  0.643
  T1                                      15                 82                                           15            23            
  T2                                      8                  83                                           8             18            
  T3                                      10                 135                                          10            16            
  T4a                                     18                 166                                          18            45            
  Nodal status (N)                                                                             0.729                                  0.534
  N0                                      21                 190                                          21            34            
  N1                                      11                 77                                           11            18            
  N2                                      5                  66                                           5             10            
  N3                                      14                 123                                          14            40            
  UICC stage                                                                                   0.319                                  0.502
  I                                       13                 78                                           13            18            
  II                                      17                 159                                          17            40            
  III                                     21                 219                                          21            44            

BMI: Body mass index; UICC stage: 7^th^ edition of the International Union against Cancer.

Perioperative results
---------------------

After matching, blood loss and postoperative days of hospital stay were significantly less in group T than in group A (*P* \< 0.05). The number of harvested lymph nodes, operative time, time to first flatus, time to fluid diet, and hospitalization costs were similar in the two groups (Table [4](#T4){ref-type="table"}).

###### 

Operative variables of the patients

                                           **All patients**   **Propensity-matched patients**                                           
  ---------------------------------------- ------------------ --------------------------------- ------- --------------- --------------- -------
  Operative time, min (mean ± SD)          209.3 ± 41.0       203.6 ± 49.3                      0.427   209.3 ± 41.0    200.5 ± 55.6    0.318
  Blood loss, mL (mean ± SD)               48.3 ± 38.5        98.4 ± 149.1                      0.017   48.3 ± 38.5     105.4 ± 147.9   0.008
  Harvested LNs (mean ± SD)                44.5 ± 15.0        41.2 ± 14.2                       0.237   44.5 ± 15.0     42.6 ± 15.2     0.465
  Time to first flatus, days (mean ± SD)   3.8 ± 1.2          3.5 ± 1.7                         0.220   3.8 ± 1.2       3.6 ± 1.2       0.332
  Time to fluid diet, days (mean ± SD)     5.6 ± 1.4          5.6 ± 1.6                         1       5.6 ± 1.4       5.5 ± 1.9       0.739
  Postoperative days (mean ± SD)           12.6 ± 4.3         14.7 ± 8.9                        0.097   12.6 ± 4.3      15.4 ± 8.9      0.035
  hospitalization costs, yuan              75450 ± 20038      73308 ± 21932                     0.505   75450 ± 20038   70407 ± 13254   0.065
  Chemotherapy                             33                 310                               0.635   33              78              0.123

LN: Lymph node.

Postoperative complications
---------------------------

Before matching, one patient had an anastomotic fistula in group T. In contrast, Group A included 22 patients with anastomotic fistula, one with anastomotic hemorrhage and four with anastomotic obstruction. The incidences of anastomosis-related complications were 2.0% and 5.9% in groups T and A, respectively; the two rates were similar. After matching, there was one patient with anastomotic fistula in group T, whereas there were four patients with anastomotic fistula, one with anastomotic hemorrhage, and two with an anastomotic obstruction in group A. The incidence of anastomosis-related complications had no statistical difference in the two groups, and no perioperative deaths occurred (Table [5](#T5){ref-type="table"}).

###### 

Morbidity and mortality associate with anastomosis

                            **All patients**   **Propensity-matched patients**                                
  ------------------------- ------------------ --------------------------------- ------- --------- ---------- -------
  Morbidity                 1 (2.0)            27 (5.9)                          0.893   1 (1.9)   6 (11.8)   0.552
  Anastomotic fistula       1                  22                                        1         4          
  Anastomotic hemorrhage    0                  1                                         0         0          
  Anastomotic obstruction   0                  4                                         0         2          
  Mortality                 0                  0                                 /       0         0          /

Functional scales
-----------------

After matching, six patients died and one was lost to follow-up 6 mo postoperatively in group T. Eventually, 44 patients joined the questionnaire survey. In group A, ten patients died, and three were lost to follow-up. A total of 89 patients from group A participated in the questionnaire survey. The functional scales of EORTC-QLQ-C30 were all similar in both groups (Figure [2](#F2){ref-type="fig"}).

Symptom scales
--------------

After matching, the symptom scales of EORTC-QLQ-C30 and STO22 were compared. Based on the pain scales of EORTC-QLQ-C30 and dysphagia scales of EORTC QLQ-STO22, group T reported better QoL (Figure [3](#F3){ref-type="fig"}). Subgroup analyses of two items in the pain scale ("Have you felt pain?" and "Has your life been affected by pain?"), group T tended to report better QoL in "Have you felt pain?"(*P* = 0.018). In the dysphagia scale, subgroup analyses of three items ("Have you had difficulty eating solid food?", "Have you had difficulty swallowing liquid or eating soft food?", and "Have you had difficulty drinking water?") revealed that group T tended to report better QoL in response to the question "Have you had difficulty eating solid food?" than group A (*P* = 0.039) (Table [6](#T6){ref-type="table"}).

![The functional scales. A: EORTC-QLQ-C30; B: EORTC-QLQ-C30 and EORTC-QLQ-STO22. ^a^*P* \< 0.05, EORTC-QLQ-C30 *vs* EORTC-QLQ-STO22.](WJG-23-7129-g003){#F3}

###### 

Constituent items of pain of EORTC-QLQ-C30 and dysphagia of EORTC-QLQ-STO22 as compared between group T and group A

                                                        **Propensity-matched patients**        
  ----------------------------------------------------- --------------------------------- ---- -------
  Constituent items of pain of EORTC-QLQ-C30                                                   
  Have you felt pain?                                                                          0.018
  Not at all                                            28                                66   
  A little                                              12                                7    
  Quite a lot                                           3                                 14   
  Very much                                             1                                 2    
  Have your life affected by pain?                                                             0.271
  Not at all                                            39                                73   
  A little                                              4                                 7    
  Quite a lot                                           1                                 9    
  Very much                                             0                                 0    
  Constituent items of dysphagia of EORTC-QLQ-STO22                                            
  Have you felt difficult to eat solid food?                                                   0.039
  Not at all                                            26                                31   
  A little                                              11                                32   
  Quite a lot                                           7                                 21   
  Very much                                             0                                 5    
  Have you felt difficult to eat liquid of soft food?                                          0.275
  Not at all                                            38                                67   
  A little                                              5                                 15   
  Quite a lot                                           1                                 7    
  Very much                                             0                                 0    
  Have you felt difficult to drink water?                                                      0.194
  Not at all                                            39                                80   
  A little                                              5                                 5    
  Quite a lot                                           0                                 4    
  Very much                                             0                                 0    

DISCUSSION
==========

Laparoscopy offers several advantages over traditional laparotomy, such as reduced trauma, faster recovery, fewer postoperative complications, and greater aesthetic appeal. These benefits are attributable to the minimal invasiveness of laparoscopy and the good clinical outcomes that have been reported\[[@B22]-[@B25]\]. Currently, the methods of digestive tract reconstruction employed after LG include LATG and TLTG. In LATG, the digestive tract reconstruction is performed *via* a small incision after lymphadenectomy, although this decreases the advantages of laparoscopic minimally invasive surgery. Since Uyama et al\[[@B12]\] reported totally laparoscopic digestive tract reconstruction, substantial research in Japan and Korea has revealed that TLTG has desirable short-term outcomes and is also safe and effective\[[@B11],[@B26]-[@B28]\].

Currently, the digestive tract reconstruction methods used after TLTG include overlap\[[@B12]\] and functional end-to-end\[[@B29]\] techniques. However, jejunal freeness is one of several drawbacks associated with these methods and makes the anastomosis more difficult. Therefore, we devised the IJOM, which involves esophagojejunostomy anastomosis after TLTG. We believe that, using this technique, the jejunum can be more easily positioned, thereby reducing the difficulty in creating the anastomosis. Moreover, because the proximal jejunum is divided after the anastomosis, the length of the blind loops can be easily grasped. We found that blood loss was reduced in group T, and this may be attributed to the clearer, amplified field of vision achieved during laparoscopic digestive tract reconstruction. As a result, blood vessels in the muscles and mesentery can be more readily identified and are less likely to be transected during the procedure. Consistent with our findings, previous studies have shown that reduced blood loss is associated with better postoperative recovery\[[@B30]\]. We found that the length of the postoperative stay in group T was significantly shorter than that in group A, confirming that less trauma and blood loss during TLTG can promote faster recovery.

Lee et al\[[@B31]\] showed that distal gastrectomy decreases the QoL because of problems with eating restrictions and body image. However, compared with open surgery, laparoscopic-assisted distal gastrectomy improves QoL, specifically by reducing the incidence of postoperative intestinal obstruction\[[@B32]\]. Fujii et al\[[@B33]\] suggested that this reduction in postoperative intestinal obstruction may be attributable to the less abdominal manipulation required for laparoscopic surgery, which may blunt the systemic cytokine and inflammatory responses\[[@B34],[@B35]\]. Similarly, totally laparoscopic technology reduces the amount of intestinal manipulation required during digestive tract reconstruction and may also reduce the incidence of postoperative intestinal obstruction. However, no studies have evaluated QoL following totally laparoscopic surgery. Schneider et al\[[@B36]\] reported that the diameter of the anastomotic stoma obtained using the linear stapler was significantly larger than that achieved with the circular stapler, which benefits the passage of food. At 6 mo post-surgery, we found that symptoms of dysphagia were better in group T, especially in terms of eating solid food. This finding indicates that using a linear stapler can expand the diameter of the anastomotic stoma and that the decreased intestinal manipulation involved in TLTG can reduce the incidence of intestinal obstruction.

Patients who underwent TLTG reported significantly less pain than those undergoing LATG. We believe that this is because the incision in the abdominal wall involved in TLTG is shorter, leading to less pain from inflammation and scar formation. In addition, less intra-abdominal manipulation likely contributes to decreasing the formation of intra-abdominal adhesions and, thus, the associated discomfort.

This is the first study investigating the differences in short-term outcomes and QoL between the IJOM after TLTG and Roux-en-Y anastomosis after LATG using PSM and a QoL assessment scale. The results show that utilizing the IJOM after TLTG can reduce intra-operative blood loss and relieve symptoms of pain and dysphagia. However, this study has several limitations. First, the follow-up period was short. Second, a retrospective, single-center design was used. Therefore, a prospective, multiple-center study with a longer follow-up period is needed.

COMMENTS
========

Background
----------

Surgeons have primarily adopted several methods for digestive tract reconstruction after totally laparoscopic total gastrectomy (TLTG). However, these methods have drawbacks, such as jejunal freeness and difficult to perform. Therefore, we devised the isoperistaltic jejunum-later-cut overlap method (IJOM), but little is known about the short-term outcome and quality-of-life (QoL) in patients following the implementation of this digestive reconstruction.

Research frontiers
------------------

The QoL after distal gastrectomy was reported to be affected by eating restrictions and body image. For TLTG, scholars have reported a variety of digestive reconstruction methods which are safe and effective, but the QoL is uncertain.

Innovations and breakthroughs
-----------------------------

The authors used propensity score-matched analysis and questionnaire survey to perform this research. The authors found that IJOM for digestive reconstruction can reduce blood loss compared with Roux-en-Y anastomosis and was associated with less pain and dysphagia, thus improving QoL after laparoscopic gastrectomy.

Applications
------------

Through this study, we can focus the symptoms which probably happen after surgery and accordingly improve the QoL of patients. However, a prospective, multiple-center study with a longer follow-up period is needed.

Terminology
-----------

EORTC-QLQ-C30: Chinese version of the European Organization for Research and Treatment of Cancer 30-item core QoL questionnaire. EORTC-QLQ-STO22: the validated Chinese version of the 22-item EORTC-QLQ gastric cancer module. PSM: A statistical matching method which can reduce the bias of variables.

Peer-review
-----------

This study is a pioneer study about esophagojejunostomy anastomosis after TLTG.
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